Yes. Trygg Pharma was formerly owned by 1 private investor.
Trygg Pharma is headquartered in Oslo, Norway.
Trygg Pharma is a life science company.
Trygg Pharma was founded in 2009.
Trygg Pharma is a Norwegian-based 50/50 joint venture with Aker BioMarine. TPH is a manufacturer of marine-based omega-3 EPA/DHA concentrates for nutraceutical and pharmaceutical applications. EPAX, TPH’s nutraceutical division, is a long-standing leader in marine-based omega-3 EPA/DHA fatty acid concentrates for nutraceutical manufacturers and marketers, with a focus on the high concentrate segment. Trygg Pharma, TPH’s pharmaceutical division, is completing a Phase III FDA study on an omega-3-based drug candidate for hypertriglyceridemia. Trygg Pharma was founded in 2009 and is based in Oslo, Norway.
| Year | '09 | '10 | '11 | '12 | '13 | T | ||
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | 1 | - | - | - | 1 | |
| Sell (0.2/yr) | # | - | - | - | - | 1 | 1 | |
| vol | $345M | $345M | ||||||
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
